Differences in medical care costs for recurrent versus de novo stage IV cancer by age at diagnosis.
Matthew P. Banegas(Kaiser Permanente Center for Health Research), Debra P. Ritzwoller(Kaiser Permanente), Nikki M. Carroll(Kaiser Permanente), Michael J. Hassett(Harvard University), Maureen O’Keeffe‐Rosetti(Kaiser Permanente Center for Health Research), Mark C. Hornbrook(Kaiser Permanente Center for Health Research), Angel M. Cronin, Hajime Uno(Dana-Farber Cancer Institute), Paul Fishman(Department of Health)
Cited by 0
Related Papers
On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
|Statistics in Medicine|2011|1.5k
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
|New England Journal of Medicine|2012|1.1k
Acupuncture for Chronic Pain
|Archives of Internal Medicine|2012|976
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
|Journal of Clinical Oncology|2014|777
Associations Between End-of-Life Discussion Characteristics and Care Received Near Death: A Prospective Cohort Study
|Journal of Clinical Oncology|2012|572